Ribavirin aerosol treatment of influenza B virus infection.
about
Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agentInhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitroActivity of selenazofurin against influenza A and B viruses in vitroMegaRibavirin aerosol for the treatment of influenza A virus infections in miceTreatment of influenza A (H1N1) virus infection with ribavirin aerosolHemodialysis clearance of intravenously administered ribavirin.Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes.Respiratory syncytial virus infections.Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cellsProtection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosolAntiviral therapy: current concepts and practicesIn vitro and in vivo effects of ribavirin on human respiratory epitheliumBiochemistry and clinical applications of ribavirin.Ribavirin small-particle-aerosol treatment of influenza B virus infection.Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro.Evaluation of a monoclonal antibody pool for rapid diagnosis of respiratory viral infections.Ribavirin and acute bronchiolitis in infancy.Antiviral therapy. New drugs and their uses.Comparison of oral and aerosol ribavirin regimens in the high risk elderly.
P2860
Q27478297-A5D2983D-728D-4760-89B7-20F6C5582FDFQ28361333-F35F800F-A764-4C31-8854-2C8D53F63EC9Q28362680-7CFE24CD-2A34-4265-9073-9D2C515454A6Q30367819-A7BC8BC0-4742-4FB3-89C4-F012F84FB8D1Q33737311-3BD6C14B-9025-400C-88A7-DC6D4293074AQ35251131-466E4BF4-51F4-4B0A-9593-60042637109FQ35309733-404A3DC3-A69B-4A52-86F6-F73D0C06AC33Q35480437-00E9F296-DD4E-43BD-9881-E12CC3FDD9E3Q35570322-9A27D98C-4F27-4CCE-812D-BE2063F1966EQ35650364-6F1BDDDC-ED0D-4496-9910-C32E4C199665Q35653947-D27CC5B1-F6B1-4EB2-B5A8-ED4BFD3309B6Q36070394-25311B4A-3AE1-451B-B52C-98A134E96E29Q36215117-B25BF405-1D49-4E63-987C-6C0E45331899Q39460438-B8DE2093-7396-4835-91A4-E97884C449D2Q39818236-BEA9ABC1-7943-4866-A779-E47C83DB8A22Q39818358-1AB12A3D-4920-4D2D-ABF3-249BEF2513A4Q40198701-9CF50E5F-DD1F-4B98-9311-969FA67B63B8Q42882400-142CB98D-BA62-4B88-B89C-83F555538AB3Q43669773-72F53674-9BE1-4FE8-B6F3-64C941B53C2CQ50590677-CDCADDB0-C1BD-4697-B98D-C2E7BFAB192E
P2860
Ribavirin aerosol treatment of influenza B virus infection.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Ribavirin aerosol treatment of influenza B virus infection.
@en
type
label
Ribavirin aerosol treatment of influenza B virus infection.
@en
prefLabel
Ribavirin aerosol treatment of influenza B virus infection.
@en
P2093
P1476
Ribavirin aerosol treatment of influenza B virus infection.
@en
P2093
B E Gilbert
G W Divine
H W McClung
J M Quarles
S Z Wilson
P304
P356
10.1001/JAMA.1983.03330430047028
P407
P577
1983-05-01T00:00:00Z